Skip to main content
25 October 2016
WHO/BS/2016.2281 Collaborative study on the 2nd IS for Blood Coagulation Factor XI, Plasma (15/180)
WHO/BS/2016.2281 Collaborative study on the 2nd IS for Blood Coagulation Factor XI, Plasma (15/180)
25 October 2016
WHO/BS/2016.2282 An international collaborative study to calibrate the WHO 2nd IS for Ancrod (15/106) and the WHO Reference Reagent for Batroxobin
WHO/BS/2016.2282 An international collaborative study to calibrate the WHO 2nd IS for Ancrod (15/106) and the WHO Reference Reagent for Batroxobin
25 October 2016
WHO/BS/2016.2286 Collaborative Study to Evaluate a Candidate WHO IS for Zika Virus for Nucleic Acid Amplification Technique (NAT)-Based Assays
WHO/BS/2016.2286 Collaborative Study to Evaluate a Candidate WHO IS for Zika Virus for Nucleic Acid Amplification Technique (NAT)-Based Assays
25 October 2016
WHO/BS/2016.2291 Collaborative Study to Evaluate the Proposed WHO 4th IS for Hepatitis B Virus (HBV) DNA for Nucleic Acid Amplification Technique (NAT) based assays
WHO/BS/2016.2291 Collaborative Study to Evaluate the Proposed WHO 4th IS for Hepatitis B Virus (HBV) DNA for Nucleic Acid Amplification Technique (NAT) based assays
25 October 2016
WHO/BS/2016.2292 WHO International Collaborative Study of the Proposed 4th IS for Prolactin, Human
WHO/BS/2016.2292 WHO International Collaborative Study of the Proposed 4th IS for Prolactin, Human
25 October 2016
WHO/BS/2016.2293 Collaborative study to evaluate the proposed WHO 1st International Reference Panel for Genomic JAK2 V617F
WHO/BS/2016.2293 Collaborative study to evaluate the proposed WHO 1st International Reference Panel for Genomic JAK2 V617F
25 October 2016
WHO/BS/2016.2294 Calibration of the Proposed 5th IS for Thromboplastin, human, recombinant, plain (rTF/16; study code 14/001) and the Proposed 5th IS for Thromboplastin, rabbit, plain (RBT/16; study code 15/001)
WHO/BS/2016.2294 Calibration of the Proposed 5th IS for Thromboplastin, human, recombinant, plain (rTF/16; study code 14/001) and the Proposed 5th IS for Thromboplastin, rabbit, plain (RBT/16; study code 15/001)
25 October 2016
WHO/BS/2016.2295 Requests to initiate new WHO reference material projects for vaccines and
related substances
WHO/BS/2016.2295 Requests to initiate new WHO reference material projects for vaccines and
related substances
25 October 2016
WHO/BS/2016.2296.Rev.1 Requests to initiate new WHO reference material projects for biotherapeutics
(other than blood products)
WHO/BS/2016.2296.Rev.1 Requests to initiate new WHO reference material projects for biotherapeutics
(other than blood products)
25 October 2016
WHO/BS/2016.2297 Requests to initiate new WHO reference material projects for blood products
WHO/BS/2016.2297 Requests to initiate new WHO reference material projects for blood products
25 October 2016
WHO/BS/2016.2298.Rev.1 Requests to initiate new WHO reference material projects for in vitro diagnostic devices and reagents
WHO/BS/2016.2298.Rev.1 Requests to initiate new WHO reference material projects for in vitro diagnostic devices and reagents
25 October 2016
WHO/BS/2016.2299 Collaborative Study to Establish a WHO International Reference Panel for Dengue Virus types 1 to 4 RNA for Nucleic Acid Amplification Technology (NAT)-Based Assays
WHO/BS/2016.2299 Collaborative Study to Establish a WHO International Reference Panel for Dengue Virus types 1 to 4 RNA for Nucleic Acid Amplification Technology (NAT)-Based Assays
25 October 2016
WHO/BS/2016.2302 WHO collaborative study to assess the suitability of a WHO International Reference Panel for Ebola virus VP40 antigen
WHO/BS/2016.2302 WHO collaborative study to assess the suitability of a WHO International Reference Panel for Ebola virus VP40 antigen
